Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neuroaxonal Dystrophies"" wg kryterium: Temat


Wyświetlanie 1-14 z 14
Tytuł:
Cerebral Iron Deposition in Neurodegeneration.
Autorzy:
Dusek P; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital in Prague, Charles University in Prague, 120 00 Prague, Czech Republic.; Department of Radiology, 1st Faculty of Medicine and General University Hospital in Prague, Charles University in Prague, 120 00 Prague, Czech Republic.
Hofer T; Department of Environmental Health, Division of Climate and Health, Norwegian Institute of Public Health, P.O. Box 222, Skøyen, 0213 Oslo, Norway.
Alexander J; Department of Environmental Health, Division of Climate and Health, Norwegian Institute of Public Health, P.O. Box 222, Skøyen, 0213 Oslo, Norway.
Roos PM; Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.; Department of Clinical Physiology, St. Goran Hospital, 112 81 Stockholm, Sweden.
Aaseth JO; Research Department, Innlandet Hospital Trust, P.O. Box 104, 2381 Brumunddal, Norway.; Faculty of Health and Social Sciences, Inland Norway University of Applied Sciences, P.O. Box 400, 2418 Elverum, Norway.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2022 May 17; Vol. 12 (5). Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Iron Metabolism Disorders*/pathology
Neuroaxonal Dystrophies*/pathology
Neurodegenerative Diseases*/pathology
Brain/pathology ; Humans ; Iron/pharmacology
Czasopismo naukowe
Tytuł:
Physiological significance of WDR45, a responsible gene for β-propeller protein associated neurodegeneration (BPAN), in brain development.
Autorzy:
Noda M; Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya, Kasugai, 480-0392, Japan.
Ito H; Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya, Kasugai, 480-0392, Japan.
Nagata KI; Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya, Kasugai, 480-0392, Japan. .; Department of Neurochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Nov 19; Vol. 11 (1), pp. 22568. Date of Electronic Publication: 2021 Nov 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nerve Degeneration*
Neurogenesis*
Brain/*metabolism
Carrier Proteins/*metabolism
Iron Metabolism Disorders/*metabolism
Neuroaxonal Dystrophies/*metabolism
Animals ; Axons/metabolism ; Axons/pathology ; Brain/embryology ; COS Cells ; Carrier Proteins/genetics ; Chlorocebus aethiops ; Dendrites/metabolism ; Dendrites/pathology ; Electrical Synapses/metabolism ; Electrical Synapses/pathology ; Gene Expression Regulation, Developmental ; Gene Knockout Techniques ; Gestational Age ; Iron Metabolism Disorders/embryology ; Iron Metabolism Disorders/genetics ; Iron Metabolism Disorders/pathology ; Mice, Inbred ICR ; Neuroaxonal Dystrophies/embryology ; Neuroaxonal Dystrophies/genetics ; Neuroaxonal Dystrophies/pathology ; Signal Transduction ; Mice
SCR Disease Name:
Neurodegeneration with brain iron accumulation (NBIA)
Czasopismo naukowe
Tytuł:
Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions.
Autorzy:
Tarnacka B; Department of Rehabilitation Medicine, Faculty of Medicine, Warsaw Medical University, Spartańska 1, 02-637 Warsaw, Poland.
Jopowicz A; Department of Rehabilitation, Eleonora Reicher National Institute of Geriatrics, Rheumatology and Rehabilitation, Spartańska 1, 02-637 Warsaw, Poland.
Maślińska M; Department of Early Arthritis, Eleonora Reicher National Institute of Geriatrics, Rheumatology and Rehabilitation, Spartańska 1, 02-637 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 22; Vol. 22 (15). Date of Electronic Publication: 2021 Jul 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Ceruloplasmin/*deficiency
Copper/*adverse effects
Iron/*adverse effects
Iron Metabolism Disorders/*pathology
Manganese/*adverse effects
Metabolic Diseases/*pathology
Neuroaxonal Dystrophies/*pathology
Neurodegenerative Diseases/*pathology
Humans ; Iron Metabolism Disorders/chemically induced ; Iron Metabolism Disorders/etiology ; Manganese Poisoning/complications ; Metabolic Diseases/chemically induced ; Metalloproteins/metabolism ; Neuroaxonal Dystrophies/chemically induced ; Neurodegenerative Diseases/etiology ; Oxidative Stress
SCR Disease Name:
Familial apoceruloplasmin deficiency; Hypermanganesemia with Dystonia Polycythemia and Cirrhosis; Neuroferritinopathy
Czasopismo naukowe
Tytuł:
Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress.
Autorzy:
Kurzawa-Akanbi M; Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.; Wolfson Building, Newcastle University, Newcastle upon Tyne, UK.
Keogh M; Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.; Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.; MRC Mitochondrial Biology Unit, Department of Clinical Neurosciences, Cambridge Biomedical Campus, Cambridge University, Cambridge, UK.
Tsefou E; Wolfson Building, Newcastle University, Newcastle upon Tyne, UK.
Ramsay L; Newcastle Brain Tissue Resource, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Academic Unit of Pathology, Royal Hallamshire Hospital, Sheffield, UK.
Johnson M; Newcastle Brain Tissue Resource, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Keers S; Newcastle Brain Tissue Resource, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Wsa Ochieng L; Wolfson Building, Newcastle University, Newcastle upon Tyne, UK.
McNair A; Wolfson Building, Newcastle University, Newcastle upon Tyne, UK.
Singh P; Wolfson Building, Newcastle University, Newcastle upon Tyne, UK.
Khan A; Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Pyle A; Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
Hudson G; Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
Ince PG; Academic Unit of Pathology, Royal Hallamshire Hospital, Sheffield, UK.
Attems J; Cellular Pathology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Burn J; Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.; Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, International Centre for Life, Newcastle upon Tyne, UK.
Chinnery PF; Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.; MRC Mitochondrial Biology Unit, Department of Clinical Neurosciences, Cambridge Biomedical Campus, Cambridge University, Cambridge, UK.
Morris CM; Wolfson Building, Newcastle University, Newcastle upon Tyne, UK.; Newcastle Brain Tissue Resource, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Pokaż więcej
Źródło:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2021 Feb; Vol. 47 (1), pp. 26-42. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Apoferritins/*metabolism
Brain/*drug effects
Iron/*metabolism
Iron Metabolism Disorders/*metabolism
Neuroaxonal Dystrophies/*metabolism
Animals ; Apoferritins/chemistry ; Apoferritins/genetics ; Brain/pathology ; Disease Models, Animal ; Ferritins/chemistry ; Ferritins/genetics ; Ferritins/metabolism ; Humans ; Iron Metabolism Disorders/pathology ; Middle Aged ; Mitochondria/drug effects ; Mitochondria/metabolism ; Mutation/genetics ; Neuroaxonal Dystrophies/pathology ; Neurodegenerative Diseases/pathology ; Oxidative Stress/drug effects ; Protein Aggregates/physiology
SCR Disease Name:
Neuroferritinopathy
Czasopismo naukowe
Tytuł:
Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect.
Autorzy:
Correa-Vela M; Department of Pediatric Neurology, Hospital Universitari Vall d'Hebron, Vall d´Hebron Institut de Recerca, Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain.
Lupo V; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.; Joint Units INCLIVA & IIS La Fe Rare Diseases, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Montpeyó M; Neurodegenerative diseases-CIBERNED, Vall d´Hebron, Institut de Recerca, Barcelona, Spain.
Sancho P; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.; Joint Units INCLIVA & IIS La Fe Rare Diseases, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Marcé-Grau A; Department of Pediatric Neurology, Hospital Universitari Vall d'Hebron, Vall d´Hebron Institut de Recerca, Barcelona, Spain.
Hernández-Vara J; Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Darling A; Department of Pediatric Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Jenkins A; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Fernández-Rodríguez S; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Tello C; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Ramírez-Jiménez L; Unit of Genomics and Traslational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Pérez B; Department of Molecular Biology, Centro de Biología Molecular Severo-Ochoa UAM-CSIC, Universidad Autónoma de Madrid, Centro de Diagnóstico de Enfermedades Moleculares (CEDEM), CIBER on Rare Diseases (CIBERER), Instituto de Investigación Sanitaria Hospital La Paz (IdiPaz), Madrid, Spain.
Sánchez-Montáñez Á; Department of Pediatric Radiology, Hospital Universitari Vall d'Hebrón, Barcelona, Spain.
Macaya A; Department of Pediatric Neurology, Hospital Universitari Vall d'Hebron, Vall d´Hebron Institut de Recerca, Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain.
Sobrido MJ; Neurogenetics Research Group, Instituto de Investigaciones Sanitarias (IDIS), Fundación Pública Galega de Medicina Xenómica, and CIBER on Rare Diseases (CIBERER), Santiago de Compostela, Spain.
Martinez-Vicente M; Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Pérez-Dueñas B; Department of Pediatric Neurology, Hospital Universitari Vall d'Hebron, Vall d´Hebron Institut de Recerca, Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain.
Espinós C; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.; Joint Units INCLIVA & IIS La Fe Rare Diseases, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Aug; Vol. 7 (8), pp. 1436-1442. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Iron Metabolism Disorders*/enzymology
Iron Metabolism Disorders*/genetics
Iron Metabolism Disorders*/pathology
Iron Metabolism Disorders*/physiopathology
Neuroaxonal Dystrophies*/enzymology
Neuroaxonal Dystrophies*/genetics
Neuroaxonal Dystrophies*/pathology
Neuroaxonal Dystrophies*/physiopathology
Parkinsonian Disorders*/enzymology
Parkinsonian Disorders*/genetics
Parkinsonian Disorders*/pathology
Parkinsonian Disorders*/physiopathology
F-Box Proteins/*genetics
Proteasome Endopeptidase Complex/*metabolism
Adult ; Consanguinity ; Epilepsy/enzymology ; Epilepsy/genetics ; Epilepsy/pathology ; Epilepsy/physiopathology ; Female ; Humans ; Paraplegia/enzymology ; Paraplegia/genetics ; Paraplegia/pathology ; Paraplegia/physiopathology ; Spinocerebellar Degenerations/enzymology ; Spinocerebellar Degenerations/genetics ; Spinocerebellar Degenerations/pathology ; Spinocerebellar Degenerations/physiopathology ; Syndrome ; Young Adult
SCR Disease Name:
Neurodegeneration with brain iron accumulation (NBIA)
Czasopismo naukowe
Tytuł:
Palliative care in 9 children with neurodegeneration with brain iron accumulation.
Autorzy:
Dangel T; Warsaw Hospice for Children Foundation, Agatowa 10, 03-680, Warsaw, Poland. .
Kmieć T; Department of Neurology and Epileptology, Children's Memorial Health Institute, Warsaw, Poland.
Januszaniec A; Warsaw Hospice for Children Foundation, Agatowa 10, 03-680, Warsaw, Poland.
Ważny B; Warsaw Hospice for Children Foundation, Agatowa 10, 03-680, Warsaw, Poland.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2020 Mar; Vol. 41 (3), pp. 653-660. Date of Electronic Publication: 2019 Nov 22.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Home Care Services*
Iron Metabolism Disorders/*therapy
Neuroaxonal Dystrophies/*therapy
Neuromuscular Agents/*pharmacology
Palliative Care/*methods
Adolescent ; Bone Diseases/drug therapy ; Bone Diseases/etiology ; Botulinum Toxins/pharmacology ; Child ; Dystonia/drug therapy ; Dystonia/etiology ; Female ; Humans ; Iron Metabolism Disorders/complications ; Iron Metabolism Disorders/drug therapy ; Iron Metabolism Disorders/nursing ; Male ; Muscle Spasticity/drug therapy ; Muscle Spasticity/etiology ; Musculoskeletal Pain/drug therapy ; Musculoskeletal Pain/etiology ; Neuroaxonal Dystrophies/complications ; Neuroaxonal Dystrophies/drug therapy ; Neuroaxonal Dystrophies/nursing
SCR Disease Name:
Neurodegeneration with brain iron accumulation (NBIA)
Czasopismo naukowe
Tytuł:
Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
Autorzy:
Kaur J; Department of Neurology, Dayanand Medical College & Hospital, Civil Lines, Ludhiana, India.
Parveen S; Genomics and Molecular Medicine, CSIR - Institute of Genomics and Integrative Biology, Delhi, India.
Shamim U; Genomics and Molecular Medicine, CSIR - Institute of Genomics and Integrative Biology, Delhi, India.
Sharma P; Genomics and Molecular Medicine, CSIR - Institute of Genomics and Integrative Biology, Delhi, India.
Suroliya V; Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.
Sonkar AK; Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.
Ahmad I; Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.
Garg J; Department of Neurology, Post Graduate Institute of Medical Education and Research, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Anand KS; Department of Neurology, Post Graduate Institute of Medical Education and Research, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Laskar S; Departmentt of Neurology, Safdurjung Hospital, Delhi, India.
Chowdhury D; Department of Neurology, GB Pant Hospital, Delhi, India.
Kushwaha S; Department of Neurology, Institute of Human Behaviour and Allied Sciences, Delhi, India.
Goyal V; Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.
Srivastava AK; Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.
Singh G; Department of Neurology, Dayanand Medical College & Hospital, Civil Lines, Ludhiana, India.
Faruq M; Genomics and Molecular Medicine, CSIR - Institute of Genomics and Integrative Biology, Delhi, India.
Pokaż więcej
Źródło:
Journal of Huntington's disease [J Huntingtons Dis] 2020; Vol. 9 (3), pp. 283-289.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heredodegenerative Disorders, Nervous System/*diagnosis
Huntington Disease/*diagnosis
Iron Metabolism Disorders/*diagnosis
Neuroaxonal Dystrophies/*diagnosis
Trinucleotide Repeat Expansion/*genetics
Adult ; Female ; Genetic Testing ; Heredodegenerative Disorders, Nervous System/genetics ; Humans ; Huntingtin Protein ; Huntington Disease/genetics ; India ; Iron Metabolism Disorders/genetics ; Male ; Middle Aged ; Nerve Tissue Proteins ; Neuroaxonal Dystrophies/genetics ; Protein Phosphatase 2 ; TATA-Box Binding Protein
SCR Disease Name:
Huntington Disease-Like Syndrome; Neuroferritinopathy
Czasopismo naukowe
Tytuł:
Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).
Autorzy:
Gregory A; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Lotia M; Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas.
Jeong SY; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Fox R; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Zhen D; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Sanford L; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Hamada J; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Jahic A; Department of Clinical Chemistry, Jena University Hospital, Jena, Germany.
Beetz C; Department of Clinical Chemistry, Jena University Hospital, Jena, Germany.
Freed A; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Kurian MA; Developmental Neurosciences, GOSH-Institute of Child Health, UCL & Department of Neurology, Great Ormond Street Hospital, London, UK.
Cullup T; North East Thames Regional Genetics Laboratory, London, UK.
van der Weijden MCM; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands.
Nguyen V; Pathology, Oregon Health & Science University, Portland, Oregon.
Setthavongsack N; Pathology, Oregon Health & Science University, Portland, Oregon.
Garcia D; Pathology, Oregon Health & Science University, Portland, Oregon.
Krajbich V; Pathology, Oregon Health & Science University, Portland, Oregon.
Pham T; Pathology, Oregon Health & Science University, Portland, Oregon.
Woltjer R; Pathology, Oregon Health & Science University, Portland, Oregon.
George BP; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
Minks KQ; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
Paciorkowski AR; Department of Neurology, University of Rochester Medical Center, Rochester, New York.; Departments of Pediatrics, Biomedical Genetics, and Neuroscience, University of Rochester Medical Center, Rochester, New York.
Hogarth P; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Jankovic J; Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas.
Hayflick SJ; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2019 Jul; Vol. 7 (7), pp. e00736. Date of Electronic Publication: 2019 May 13.
Typ publikacji:
Journal Article
MeSH Terms:
Iron Metabolism Disorders/*genetics
Membrane Proteins/*genetics
Mitochondrial Proteins/*genetics
Neuroaxonal Dystrophies/*genetics
Adult ; Brain ; Codon, Nonsense/genetics ; Cohort Studies ; Family ; Female ; Genes, Dominant/genetics ; Heterozygote ; Humans ; Iron Metabolism Disorders/metabolism ; Male ; Mitochondrial Membranes/metabolism ; Mitochondrial Proteins/metabolism ; Mutation ; Neuroaxonal Dystrophies/metabolism ; Neurodegenerative Diseases/genetics ; Neurodegenerative Diseases/metabolism ; Pedigree
SCR Disease Name:
Neurodegeneration with brain iron accumulation (NBIA)
Czasopismo naukowe
Tytuł:
Mitochondrial membrane protein-associated neurodegeneration: a case report and literature review.
Autorzy:
Dušek P; a Department of Neurology, Centre of Clinical Neurosciences, 1st Faculty of Medicine , Charles University and General University Hospital , Prague , Czech Republic.
Školoudík D; b Center of Research and Science, Faculty of Health Sciences , Palacký University , Olomouc , Czech Republic.
Roth J; a Department of Neurology, Centre of Clinical Neurosciences, 1st Faculty of Medicine , Charles University and General University Hospital , Prague , Czech Republic.
Dušek P; a Department of Neurology, Centre of Clinical Neurosciences, 1st Faculty of Medicine , Charles University and General University Hospital , Prague , Czech Republic.; c Department of Radiology, First Faculty of Medicine , Charles Universityand GeneralUniversity Hospital in Prague , Prague , Czech Republic.
Pokaż więcej
Źródło:
Neurocase [Neurocase] 2018 Jun; Vol. 24 (3), pp. 161-165. Date of Electronic Publication: 2018 Aug 08.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Iron Metabolism Disorders*/diagnostic imaging
Iron Metabolism Disorders*/genetics
Iron Metabolism Disorders*/physiopathology
Mitochondrial Membrane Transport Proteins*
Neuroaxonal Dystrophies*/diagnostic imaging
Neuroaxonal Dystrophies*/genetics
Neuroaxonal Dystrophies*/physiopathology
Interleukins/*genetics
Adult ; Humans ; Male ; Young Adult
SCR Disease Name:
Neurodegeneration with brain iron accumulation (NBIA)
Czasopismo naukowe
Tytuł:
Different cortical excitability profiles in hereditary brain iron and copper accumulation.
Autorzy:
Dubbioso R; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy. .
Ruggiero L; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
Esposito M; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
Tarantino P; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
De Angelis M; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
Aruta F; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
Pappatà S; Institute of Biostructure and Bioimaging, National Council of Research, Via S. Pansini, 5 IT-80131, Napoli, Italy.
Ugga L; Department of Advanced Biomedical Sciences, University of Naples 'Federico II', Naples, Italy.
Piperno A; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Iorio R; Department of Translational Medical Sciences, Section of Pediatrics, University of Naples 'Federico II', Naples, Italy.
Santoro L; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
Iodice R; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
Manganelli F; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2020 Mar; Vol. 41 (3), pp. 679-685. Date of Electronic Publication: 2019 Nov 26.
Typ publikacji:
Journal Article
MeSH Terms:
Ceruloplasmin/*deficiency
Cortical Excitability/*physiology
Hepatolenticular Degeneration/*physiopathology
Iron Metabolism Disorders/*physiopathology
Neuroaxonal Dystrophies/*physiopathology
Neurodegenerative Diseases/*physiopathology
Parkinsonian Disorders/*physiopathology
Adult ; Female ; Humans ; Male ; Middle Aged ; Transcranial Magnetic Stimulation ; Young Adult
SCR Disease Name:
Familial apoceruloplasmin deficiency; Neurodegeneration with brain iron accumulation (NBIA)
Czasopismo naukowe
Tytuł:
Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy.
Autorzy:
Garringer HJ; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Irimia JM; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Li W; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Goodwin CB; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Richine B; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Acton A; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Chan RJ; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Peacock M; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Muhoberac BB; Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, Indianapolis, Indianam 46202, United States of America.
Ghetti B; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Vidal R; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Aug 30; Vol. 11 (8), pp. e0161341. Date of Electronic Publication: 2016 Aug 30 (Print Publication: 2016).
Typ publikacji:
Journal Article
MeSH Terms:
Apoferritins/*metabolism
Fibroblasts/*drug effects
Iron Chelating Agents/*administration & dosage
Iron Metabolism Disorders/*drug therapy
Iron Overload/*drug therapy
Neuroaxonal Dystrophies/*drug therapy
Pyridones/*administration & dosage
Animals ; Cell Survival ; Cells, Cultured ; Chelation Therapy ; Deferiprone ; Disease Models, Animal ; Female ; Fibroblasts/cytology ; Fibroblasts/metabolism ; Humans ; Iron/adverse effects ; Iron Chelating Agents/pharmacology ; Iron Metabolism Disorders/metabolism ; Iron Overload/metabolism ; Male ; Mice ; Neuroaxonal Dystrophies/metabolism ; Oxidative Stress/drug effects ; Pyridones/pharmacology
SCR Disease Name:
Neuroferritinopathy
Czasopismo naukowe
Tytuł:
Behavioral characterization of mouse models of neuroferritinopathy.
Autorzy:
Capoccia S; Department of Cell Biology, Section of Behavioral Neuroscience, Istituto Superiore Di Sanità, Rome, Italy.
Maccarinelli F; Department of Molecular and Translational Medicine, Section of Biotechnologies, University of Brescia, Brescia, Italy.
Buffoli B; Department of Clinical and Experimental Sciences, Section of Anatomy and Physiopathology, University of Brescia, Brescia, Italy.
Rodella LF; Department of Clinical and Experimental Sciences, Section of Anatomy and Physiopathology, University of Brescia, Brescia, Italy.
Cremona O; Università Vita-Salute San Raffaele & Centro di Imaging Sperimentale, Istituto Scientifico San Raffaele, Milano, Italy.
Arosio P; Department of Molecular and Translational Medicine, Section of Biotechnologies, University of Brescia, Brescia, Italy.
Cirulli F; Department of Cell Biology, Section of Behavioral Neuroscience, Istituto Superiore Di Sanità, Rome, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Feb 17; Vol. 10 (2), pp. e0118990. Date of Electronic Publication: 2015 Feb 17 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Behavior, Animal*
Iron Metabolism Disorders*/genetics
Iron Metabolism Disorders*/metabolism
Iron Metabolism Disorders*/physiopathology
Neuroaxonal Dystrophies*/genetics
Neuroaxonal Dystrophies*/metabolism
Neuroaxonal Dystrophies*/physiopathology
Animals ; Apoferritins/genetics ; Disease Models, Animal ; Humans ; Mice ; Mice, Transgenic ; Mutation ; Phosphoglycerate Kinase/genetics ; Postural Balance ; Promoter Regions, Genetic ; Psychomotor Performance
SCR Disease Name:
Neuroferritinopathy
Czasopismo naukowe
Tytuł:
Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex.
Autorzy:
Kapoor S; Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, 560012, India.
Shah MH; Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, 560012, India.
Singh N; Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, 560012, India.
Rather MI; Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, 560012, India.
Bhat V; Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, 560012, India.
Gopinath S; Department of Biotechnology, R.V. College of Engineering, Bangalore, 560059, India.
Bindu PS; Department of Neurology, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
Taly AB; Department of Neurology, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
Sinha S; Department of Neurology, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
Nagappa M; Department of Neurology, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
Bharath RD; Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
Mahadevan A; Department of Neuropathology, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
Narayanappa G; Department of Neuropathology, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
Chickabasaviah YT; Department of Neuropathology, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
Kumar A; Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, 560012, India.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 May 19; Vol. 11 (5), pp. e0155605. Date of Electronic Publication: 2016 May 19 (Print Publication: 2016).
Typ publikacji:
Journal Article
MeSH Terms:
Dystonia/*genetics
Group VI Phospholipases A2/*genetics
Iron Metabolism Disorders/*genetics
Neuroaxonal Dystrophies/*genetics
Parkinsonian Disorders/*genetics
Alleles ; Asian People/genetics ; Dystonic Disorders/genetics ; Exons ; Family Health ; Female ; Genetic Predisposition to Disease ; Genetic Testing ; Homozygote ; Humans ; India ; Magnetic Resonance Imaging ; Male ; Mutation ; Neurodegenerative Diseases/genetics
SCR Disease Name:
NBIA2B
Czasopismo naukowe
    Wyświetlanie 1-14 z 14

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies